MedPath

Evaluation of serial self-testing supported contact tracing for COVID-19 in Brazil

Not Applicable
Completed
Conditions
COVID-19 (SARS-CoV-2 infection)
Infections and Infestations
Registration Number
ISRCTN91602092
Lead Sponsor
PATH
Brief Summary

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37792740/ (added 05/10/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
793
Inclusion Criteria

1. Participants will be confirmed COVID-19 cases (index cases) and their associated close contacts.
2. Index cases will be 7 years of age or older.
3. Primary exposure close contacts will be enrolled in the main study, including children aged 7 and older.
4. Secondary exposure close contacts (household members of primary exposure close contacts enrolled in Arm 2) will be given self-tests to use in the observational sub-study.
5. A subset of patients/primary exposure close contacts, caregivers of primary exposure close contacts, health unit workers, and other key stakeholders will also have the option of participating in a usability workshop and/or focus group discussions. These participants will be aged 18 years and older

Exclusion Criteria

1. Study site employee who is involved in the protocol and may have access to study-related data
2. Inappropriate to enroll
3. Previous study participant
4. Contraindication to nasal swab

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath